Genetic counselling and genetic testing in hereditary gastrointestinal cancer syndromes

Best Practice and Research: Clinical Gastroenterology

Volumn 23, Issue 2, 2009, Pages 275-283

  Raymond, Victoria M ^a   Everett, Jessica N ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

communication barriers; duty to warn; family planning; genetic counselling; risk

Indexed keywords

ARTICLE; CANCER MORTALITY; CLINICAL PROTOCOL; DECISION MAKING; DIGESTIVE SYSTEM CANCER; FAMILIAL CANCER; FAMILY; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HIGH RISK PATIENT; HUMAN; INHERITANCE; MORBIDITY; OUTPATIENT DEPARTMENT; PATIENT IDENTIFICATION; PATIENT REFERRAL; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; SOCIAL ASPECT;

ADAPTATION, PSYCHOLOGICAL; COMMUNICATION BARRIERS; FAMILY PLANNING SERVICES; FAMILY RELATIONS; GASTROINTESTINAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC PRIVACY; GENETIC SCREENING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; NEOPLASTIC SYNDROMES, HEREDITARY; PATIENT EDUCATION AS TOPIC; PEDIGREE; PERCEPTION; PHYSICIAN-PATIENT RELATIONS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT;

EID: 65349145213     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2009.02.009     Document Type: Article

References (68)

1. Baker D.L., Schuette J.L., and Uhlmann W.R. A guide to genetic counseling. 1st ed. (1998), Wiley-Liss, Inc
2. Resta R. The historical perspective: Sheldon Reed and 50 years of genetic counseling. J Genet Couns 6 4 (1997) 375-377
3. American Society of Human Genetics. Genetic counseling. Am J Hum Genet 27 2 (1975 Mar) 240-242
4. Resta R., Biesecker B.B., Bennett R.L., et al. A new definition of Genetic Counseling: National Society of Genetic Counselors' Task Force report. J Genet Couns 15 2 (2006 Apr) 77-83
5. Vasen H.F., Mecklin J.P., Khan P.M., and Lynch H.T. The International Collaborative Group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). DisColon Rectum 34 5 (1991) 424-425
6. Umar A., Boland C.R., Terdiman J.P., et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96 4 (2004 Feb 18) 261-268
7. NCCN Clinical Practice Guidelines in Oncology. Colorectal Cancer Screening. V.2.2008 [updated V.2.2008; cited]; Available from: http://www.nccn.org/professionals/physician_gls/PDF/colorectal_screening.pdf.
8. Lindor N.M., Rabe K., Petersen G.M., et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 293 16 (2005 Apr 27) 1979-1985
9. Balaguer F., Balmana J., Castellvi-Bel S., et al. Validation and extension of the PREMM1,2 model in a population-based cohort of colorectal cancer patients. Gastroenterology 134 1 (2008 Jan) 39-46
10. Chen S., Wang W., Lee S., et al. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 296 12 (2006 Sep 27) 1479-1487
11. Ries LAG, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2005. Bethesda, MD; 2008 [updated 2008; cited based on November 2007 SEER data submission, posted to the SEER web site, 2008.]; Available from: http://seer.cancer.gov/csr/1975_2005/.
12. Galiatsatos P., and Foulkes W.D. Familial adenomatous polyposis. Am J Gastroenterol 101 2 (2006 Feb) 385-398
13. Bisgaard M.L., Fenger K., Bulow S., et al. Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat 3 2 (1994) 121-125
14. Lindor N.M., Petersen G.M., Hadley D.W., et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 296 12 (2006 Sep 27) 1507-1517
15. Mecklin J.P., Aarnio M., Laara E., et al. Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome. Gastroenterology 133 4 (2007 Oct) 1093-1098
16. Jarvinen H.J., Aarnio M., Mustonen H., et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118 5 (2000) 829-834
17. Vasen H.F., Moslein G., Alonso A., et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 57 5 (2008 May) 704-713
18. Guillem J.G., Wood W.C., Moley J.F., et al. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. Ann Surg Oncol 13 10 (2006 Oct) 1296-1321
19. Esplen M.J., Madlensky L., Butler K., et al. Motivations and psychosocial impact of genetic testing for HNPCC. Am J Med Genet 103 1 (2001 Sep 15) 9-15
20. Codori A.M., Petersen G.M., Miglioretti D.L., et al. Attitudes toward colon cancer gene testing: factors predicting test uptake. Cancer Epidemiol Biomarkers Prev 8 4 Pt 2 (1999 Apr) 345-351
21. Aktan-Collan K., Mecklin J.P., Jarvinen H., et al. Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction. Int J Cancer 89 1 (2000 Jan 20) 44-50
22. Glanz K., Grove J., Lerman C., et al. Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups. Cancer Epidemiol Biomarkers Prev 8 4 Pt 2 (1999 Apr) 329-336
23. Hadley D.W., Jenkins J., Dimond E., et al. Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer. Arch Intern Med 163 5 (2003 Mar 10) 573-582
24. Kinney A.Y., Choi Y.A., DeVellis B., et al. Attitudes toward genetic testing in patients with colorectal cancer. Cancer Pract 8 4 (2000 Jul-Aug) 178-186
25. Croyle R.T., and Lerman C. Risk communication in genetic testing for cancer susceptibility. J Natl Cancer Inst Monogr 25 (1999) 59-66
26. Kim S.E., Perez-Stable E.J., Wong S., et al. Association between cancer risk perception and screening behavior among diverse women. Arch Intern Med 168 7 (2008 Apr 14) 728-734
27. Domanska K., Nilbert M., Soller M., et al. Discrepancies between estimated and perceived risk of cancer among individuals with hereditary nonpolyposis colorectal cancer. Genet Test 11 2 (2007 Summer) 183-186
28. Aktan-Collan K., Haukkala A., Mecklin J.P., et al. Comprehension of cancer risk one and 12 months after predictive genetic testing for hereditary non-polyposis colorectal cancer. J Med Genet 38 11 (2001 Nov) 787-792
29. Gurmankin A.D., Domchek S., Stopfer J., et al. Patients' resistance to risk information in genetic counseling for BRCA1/2. Arch Intern Med 165 5 (2005 Mar 14) 523-529
30. Kelly K.M., Graves K.D., Harper F.W., et al. Assessing perceptions of cancer risk: does mode of assessment or numeracy matter?. Cancer Detect Prev 31 6 (2007) 465-473
31. Keller M., Jost R., Kadmon M., et al. Acceptance of and attitude toward genetic testing for hereditary nonpolyposis colorectal cancer: a comparison of participants and nonparticipants in genetic counseling. Dis Colon Rectum 47 2 (2004 Feb) 153-162
32. Rolland J.S., and Williams J.K. Toward a biopsychosocial model for 21st-century genetics. Fam Process 44 1 (2005 Mar) 3-24
33. Hopwood P. Psychological issues in cancer genetics: current research and future priorities. Patient Educ Couns 32 1-2 (1997 Sep-Oct) 19-31
34. Shiloh S., Koehly L., Jenkins J., et al. Monitoring coping style moderates emotional reactions to genetic testing for hereditary nonpolyposis colorectal cancer: a longitudinal study. Psychooncology 17 8 (2008 Aug) 746-755
35. Heshka J.T., Palleschi C., Howley H., et al. A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genet Med 10 1 (2008 Jan) 19-32
36. ASCO Working Group on Genetic Testing for Cancer Susceptibility. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 21 12 (2003 Jun 15) 2397-2406
37. Keller M., Jost R., Haunstetter C.M., et al. Comprehensive genetic counseling for families at risk for HNPCC: impact on distress and perceptions. Genet Test 6 4 (2002 Winter) 291-302
38. American Society of Human Genetics/American College of Medical Genetics. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Society of Human Genetics Board of Directors, American College of Medical Genetics Board of Directors. Am J Hum Genet 57 5 (1995 Nov) 1233-1241
39. Douma K.F., Aaronson N.K., Vasen H.F., and Bleiker E.M. Psychosocial issues in genetic testing for familial adenomatous polyposis: a review of the literature. Psychooncology 17 8 (2008 Aug) 737-745
40. Peterson S.K., Watts B.G., Koehly L.M., et al. How families communicate about HNPCC genetic testing: findings from a qualitative study. Am J Med Genet C Semin Med Genet 119C 1 (2003 May 15) 78-86
41. Mesters I., Ausems M., Eichhorn S., and Vasen H. Informing one's family about genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a retrospective exploratory study. Fam Cancer 4 2 (2005) 163-167
42. Stoffel E.M., Ford B., Mercado R.C., et al. Sharing genetic test results in Lynch syndrome: communication with close and distant relatives. Clin Gastroenterol Hepatol 6 3 (2008 Mar) 333-338
43. Koehly L.M., Peterson S.K., Watts B.G., et al. A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning. Cancer Epidemiol Biomarkers Prev 12 4 (2003 Apr) 304-313
44. Forrest K., Simpson S.A., Wilson B.J., et al. To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet 64 4 (2003 Oct) 317-326
45. Pentz R.D., Peterson S.K., Watts B., et al. Hereditary nonpolyposis colorectal cancer family members' perceptions about the duty to inform and health professionals' role in disseminating genetic information. Genet Test 9 3 (2005 Fall) 261-268
46. Aktan-Collan K., Haukkala A., Pylvanainen K., et al. Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing. J Med Genet 44 11 (2007 Nov) 732-738
47. Pate v. Threlkel. Wests South Rep 640 (1994 Aug 1) 183-186
48. Safer v. Estate of Pack. Atl Rep 677 (1996 Jul 11) 1188-1193
49. Offit K., Groeger E., Turner S., et al. The "duty to warn" a patient's family members about hereditary disease risks. JAMA 292 12 (2004 Sep 22) 1469-1473
50. Health Insurance Portability and Accountability Act of 1996. [updated 1996; cited]; Available from: http://aspe.hhs.gov/admnsimp/pl104191.htm.
51. Disclosure of Familial Risk in Genetic Testing: American Medical Association; 2003 [updated 2003 cited]; Available from: http://www.ama-assn.org/ama1/pub/upload/mm/31/ethicspolicies073108.pdf.
52. Offit K., Kohut K., Clagett B., et al. Cancer genetic testing and assisted reproduction. J Clin Oncol 24 29 (2006 Oct 10) 4775-4782
53. Offit K., Sagi M., and Hurley K. Preimplantation genetic diagnosis for cancer syndromes: a new challenge for preventive medicine. JAMA 296 22 (2006 Dec 13) 2727-2730
54. Whitelaw S., Northover J.M., and Hodgson S.V. Attitudes to predictive DNA testing in familial adenomatous polyposis. J Med Genet 33 7 (1996 Jul) 540-543
55. Kastrinos F., Stoffel E.M., Balmana J., and Syngal S. Attitudes toward prenatal genetic testing in patients with familial adenomatous polyposis. Am J Gastroenterol 102 6 (2007 Jun) 1284-1290
56. Jenkins M.A., Baglietto L., Dowty J.G., et al. Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study. Clin Gastroenterol Hepatol 4 4 (2006 Apr) 489-498
57. Brosens L.A., van Hattem A., Hylind L.M., et al. Risk of colorectal cancer in juvenile polyposis. Gut 56 7 (2007 Jul) 965-967
58. Merg A., and Howe J.R. Genetic conditions associated with intestinal juvenile polyps. Am J Med Genet C Semin Med Genet 129 1 (2004 Aug 15) 44-55
59. Jenkins M.A., Croitoru M.E., Monga N., et al. Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study. Cancer Epidemiol Biomarkers Prev 15 2 (2006 Feb) 312-314
60. Hearle N., Schumacher V., Menko F.H., et al. Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 12 10 (2006 May 15) 3209-3215
61. Mehenni H., Resta N., Park J.G., et al. Cancer risks in LKB1 germline mutation carriers. Gut 55 7 (2006 Jul) 984-990
62. Giardiello F.M., Brensinger J.D., Tersmette A.C., et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 119 6 (2000) 1447-1453
63. Kaurah P., MacMillan A., Boyd N., et al. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA 297 21 (2007 Jun 6) 2360-2372
64. Masciari S., Larsson N., Senz J., et al. Germline E-cadherin mutations in familial lobular breast cancer. J Med Genet 44 11 (2007 Nov) 726-731
65. Pilarski R., and Eng C. Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet 41 5 (2004 May) 323-326
66. Marsh D.J., Kum J.B., Lunetta K.L., et al. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet 8 8 (1999 Aug) 1461-1472
67. Wong P., Verselis S.J., Garber J.E., et al. Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome. Gastroenterology 130 1 (2006 Jan) 73-79
68. Lindor N.M., McMaster M.L., Lindor C.J., and Greene M.H. Concise handbook of familial cancer susceptibility syndromes - second edition. J Natl Cancer Inst Monogr 38 (2008) 1-93